News Appeals court turns Enhertu patent dispute on its head A US appeals court has reversed a 2023 decision that ordered Daiichi Sankyo to pay royalties on sales of cancer drug Enhertu to Seagen (now Pfizer).
News Eisai says patent win blocks Lenvima generic to 2036 Eisai has won a lawsuit blocking FDA approval of Shilpa's generic of cancer blockbuster Lenvima until 2036, although the verdict could go to appeal.
News UK trumpets a trade deal with India - but pharma isn't happy Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them.
News AbbVie sues Genmab, claiming trade secrets theft A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets.
News Insulin pump firm Insulet wins $452m in trade secrets clash Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.
Digital AI as an inventor: Defining ownership in the pharma sector The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.